Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

[Importance of the pre-donation epidemiological survey to detect donors with a risk of transmitting HCV].

Gimeno J, Franco E, Buñuel C, Marzo L, Giraldo P, Giralt M.

Sangre (Barc). 1994 Jun;39(3):173-6. Spanish.

PMID:
7524168
2.

Outcome of an optional HCV screening program for blood transfusion recipients in Ireland.

Davoren A, Dillon AD, Power JP, Donnellan J, Quinn JM, Willis JW, Lawlor EM, O'Riordan JM.

Transfusion. 2002 Nov;42(11):1501-6.

PMID:
12421225
3.

High rate of infectivity and liver disease in blood donors with antibodies to hepatitis C virus.

Esteban JI, López-Talavera JC, Genescà J, Madoz P, Viladomiu L, Muñiz E, Martin-Vega C, Rosell M, Allende H, Vidal X, et al.

Ann Intern Med. 1991 Sep 15;115(6):443-9.

PMID:
1651674
4.

Transmission of HCV infection by RIBA indeterminate and positive blood units.

Kolho E, Naukkarinen R, Krusius T.

Transfus Med. 1992 Sep;2(3):243-8.

PMID:
1285012
5.
6.

Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection.

Conry-Cantilena C, VanRaden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, Cheung L, DiBisceglie A, Hoofnagle J, Shih JW, et al.

N Engl J Med. 1996 Jun 27;334(26):1691-6.

7.

Risk factors associated with a high seroprevalence of hepatitis C virus infection in Egyptian blood donors.

Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R.

Am J Trop Med Hyg. 1993 Oct;49(4):440-7.

PMID:
7692754
8.

Evaluation of clinical and laboratory aspects of antibody tests for detection of hepatitis C virus infection in blood donors and recipients from a low-risk population.

MacDonald KL, Mills WA, Wood RC, Hanson M, Kline W, Bowman RJ, Polesky HF, Williams AE, Osterholm MT.

Transfusion. 1994 Mar;34(3):202-8.

PMID:
8146891
9.

Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.

García-Bengoechea M, Emparanza JI, Sarriugarte A, Cortés A, Vega JL, González F, Arenas JI.

Eur J Gastroenterol Hepatol. 1995 Mar;7(3):237-41.

PMID:
7538032
10.
11.

A high risk of hepatitis C infection among Egyptian blood donors: the role of parenteral drug abuse.

Bassily S, Hyams KC, Fouad RA, Samaan MD, Hibbs RG.

Am J Trop Med Hyg. 1995 Jun;52(6):503-5.

PMID:
7541968
12.

Detection of hepatitis C virus infection among cadaver organ donors: evidence for low transmission of disease.

Roth D, Fernandez JA, Babischkin S, De Mattos A, Buck BE, Quan S, Olson L, Burke GW, Nery JR, Esquenazi V, et al.

Ann Intern Med. 1992 Sep 15;117(6):470-5.

PMID:
1323944
13.

Clinical assessment and incidence of hepatitis C RNA in 50 consecutive RIBA-positive volunteer blood donors.

McCaughan GW, McGuinness PH, Bishop GA, Painter DM, Lien AS, Tulloch R, Wylie BR, Archer GT.

Med J Aust. 1992 Aug 17;157(4):231-3.

PMID:
1279365
14.

Evaluation of third-generation screening and confirmatory assays for HCV antibodies.

Uyttendaele S, Claeys H, Mertens W, Verhaert H, Vermylen C.

Vox Sang. 1994;66(2):122-9.

PMID:
7514324
15.

The epidemiology and infection route of asymptomatic HCV carriers detected through blood donations.

Shimoyama R, Sekiguchi S, Suga M, Sakamoto S, Yachi A.

Gastroenterol Jpn. 1993 May;28 Suppl 5:1-5.

PMID:
7689501
16.

Risk of hepatitis C infection in neonates transfused with blood from donors infected with hepatitis C.

O'Riordan JM, Conroy A, Nourse C, Yap PL, McDonald GS, Kaminski G, Leong K, Lawlor E, Davoren A, Strong K, Davidson F, Lloyd A, Power J.

Transfus Med. 1998 Dec;8(4):303-8.

PMID:
9881424
17.

Prospective study of the meaning of indeterminate results of the recombinant immunoblot assay for hepatitis C virus in blood donors.

Piro L, Solinas S, Luciani M, Casale A, Bighiani T, Santonocito D, Girelli G.

Blood Transfus. 2008 Apr;6(2):107-11.

18.
19.

Prevalence of hepatitis C virus among candidates for blood donation at the Hospital General de Mexico.

Merino-Conde E, Orozco JA, Rojo-Medina J, Tovar A.

In Vivo. 1994 Jul-Aug;8(4):621-3.

PMID:
7534495
20.

Incidence of non-A, non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers.

Barrera JM, Bruguera M, Ercilla MG, Sánchez-Tapias JM, Gil MP, Costa J, Gelabert A, Rodés J, Castillo R.

Ann Intern Med. 1991 Oct 15;115(8):596-600.

PMID:
1909848
Items per page

Supplemental Content

Support Center